Aarkstore - Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023
This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the colorectal cancer market, with coverage of multiple settings of the disease including neoadjuvant/adjuvant, first-, second-, third-line KRAS wild-type and mutation-positive, and fourth-line metastatic. Browse full report @ http://bit.ly/1HiLlHF
This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the colorectal cancer market, with coverage of multiple settings of the disease including neoadjuvant/adjuvant, first-, second-, third-line KRAS wild-type and mutation-positive, and fourth-line metastatic.
Browse full report @ http://bit.ly/1HiLlHF
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Aarks<strong>to</strong>re</strong> Enterprise<br />
Table of Content<br />
1.1 List of Tables 7<br />
2 Introduction 8<br />
2.1 Catalyst 8<br />
2.2 Related Reports 9<br />
2.3 Upcoming Related Reports 10<br />
3 Disease Overview 11<br />
3.1 Etiology <strong>and</strong> Pathophysiology 11<br />
3.1.1 Etiology 11<br />
3.1.2 Pathophysiology 13<br />
3.2 Clinical Staging 14<br />
3.3 Symp<strong>to</strong>ms 15<br />
4 Disease Management 17<br />
4.1 Diagnosis <strong>and</strong> Treatment Overview 17<br />
4.1.1 Screening <strong>and</strong> Diagnosis 17<br />
4.1.2 Treatment Guidelines <strong>and</strong> Leading Prescribed Drugs 20<br />
4.1.3 Clinical Practice 24<br />
5 Competitive Assessment 31<br />
5.1 Overview 31<br />
6 <strong>Lonsurf</strong> (TAS-102) 33<br />
6.1 Overview 33<br />
6.2 Efficacy 35<br />
6.3 Safety 36<br />
6.4 SWOT <strong>Analysis</strong> 37<br />
6.5 <strong>Forecast</strong> 37<br />
7 Appendix 39<br />
7.1 Bibliography 39
Change language